Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Peak Bio, Inc.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
09/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/28/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
08/18/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/15/2023 |
4
| Huh Hoyoung (10% Owner) has filed a Form 4 on Peak Bio, Inc.
Txns:
| Exercised (in-or-at-the-money) 583,333 options to buy
@ $0.6, valued at
$350k
|
|
08/15/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ... |
08/14/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
08/11/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
08/10/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
08/10/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
08/03/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
07/24/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
07/21/2023 |
8-K
| Quarterly results |
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/02/2023 |
4
| Huh Hoyoung (Director) has filed a Form 4 on Peak Bio, Inc.
Txns:
| Granted 1,884,625 options to buy
@ $0.6, valued at
$1.1M
Granted convertible notes
@ $1130775, valued at
$0 |
|
05/02/2023 |
4
| Neal James R (Director) has filed a Form 4 on Peak Bio, Inc.
Txns:
| Granted 33,340 options to buy
@ $0.6, valued at
$20k
Granted convertible notes
@ $20004, valued at
$0 |
|
05/01/2023 |
8-K
| Quarterly results |
04/21/2023 |
8-K
| Quarterly results |
03/31/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
03/21/2023 |
SC 13D
| Huh Hoyoung reports a 40.2% stake in Peak Bio, Inc. |
03/17/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
03/17/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office... |
03/09/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
03/03/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
03/02/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
02/28/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/28/2023 |
3
| SBI INVESTMENT KOREA CO., LTD. (10% Owner) has filed a Form 3 on Peak Bio, Inc. |
02/14/2023 |
SC 13G/A
| Vellar Opportunities Fund Master, Ltd. reports a 0% stake in IGNYTE ACQUISITION CORP. |
02/10/2023 |
SC 13G/A
| Flynn James E reports a 1.8% stake in Peak Bio, Inc. |
02/03/2023 |
SC 13G/A
| FROST PHILLIP MD ET AL reports a 1.6% stake in §240.13d-2 PEAK BIO, INC. |
01/18/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
01/09/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
01/04/2023 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Form of PIPE Subscription Agreement, by and between Peak Bio, Inc. and the Investor party thereto",
"Form of Amendment to Lock-Up Agreement",
"Amendment to Key Company Stockholder Forward Purchase Agreement, by and between Peak Bio, Inc. and Hoyoung Huh",
"Unaudited pro forma condensed combined financial information of the Company and the related notes thereto as of and for the nine months ended September 30, 2022 and for the year ended December 31, 2021" |
|
11/21/2022 |
8-K/A
| Other Events, Financial Statements and Exhibits Interactive Data |
|
|
|